Tenax Therapeutics
TENX
9 hedge funds and large institutions have $2.04M invested in Tenax Therapeutics in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
227% more capital invested
Capital invested by funds: $622K → $2.04M (+$1.41M)
0% more funds holding
Funds holding: 9 → 9 (0)
0% less ownership
Funds ownership: 0.02% → 0.02% (-0%)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$853K |
| 2 |
Renaissance Technologies
New York
|
+$109K |
| 3 |
Jane Street
New York
|
+$27.4K |
| 4 |
AG
Advisor Group
Phoenix,
Arizona
|
+$9.12K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$131K |
| 2 |
AC
Armistice Capital
New York
|
-$102K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$14K |
| 4 |
Bank of New York Mellon
New York
|
-$2.28K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$2.28K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
BlackRock
New York
| $1.21M | +$853K | +374 | New |
|
|
2
Renaissance Technologies
New York
| $489K | +$109K | +48 | +47% |
|
|
FWP
3
FAS Wealth Partners
Leawood,
Kansas
| $118K | – | – | – |
|
|
4
Bank of New York Mellon
New York
| $75K | -$2.28K | -1 | -4% |
|
5
Geode Capital Management
Boston,
Massachusetts
| $55K | – | – | – |
|
|
6
Jane Street
New York
| $39K | +$27.4K | +12 | New |
|
7
Vanguard Group
Malvern,
Pennsylvania
| $25K | – | – | – |
|
|
AG
8
Advisor Group
Phoenix,
Arizona
| $13K | +$9.12K | +4 | New |
|
|
9
UBS Group
Zurich,
Switzerland
| $12K | -$2.28K | -1 | -20% |
|
|
SM
10
Sabby Management
Miami Beach,
Florida
| – | -$131K | -68 | Closed |
|
|
AC
11
Armistice Capital
New York
| – | -$102K | -53 | Closed |
|
|
12
Citadel Advisors
Miami,
Florida
| – | -$14K | -7 | Closed |
|
TENX Hedge Fund Activity: Q1 2019 in Review
9 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Tenax Therapeutics (TENX) for Q1 2019, worth a combined $2.04M — up 227% from $622K a quarter earlier.
Fund positioning in TENX was balanced in Q1 2019: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 2 trimmed.
The largest buyer was BlackRock, opening a new position worth an estimated $853K. The largest seller was Sabby Management, exiting entirely with an estimated $131K sold.
- 9 institutional investors held Tenax Therapeutics (TENX) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $2.04M of Tenax Therapeutics stock for Q1 2019, up 227% quarter-over-quarter.
- 3 funds opened new Tenax Therapeutics positions in Q1 2019 and 3 closed out, a net change of 0 holders.
- The largest Tenax Therapeutics buyer in Q1 2019 was BlackRock, an estimated $853K added.
- The largest Tenax Therapeutics seller in Q1 2019 was Sabby Management, an estimated $131K sold.
Based on aggregated 13F filings for Q1 2019.